Matt Chandran
Week in Review: DNA is global tech media too
DNA founder Karamjit Singh ponders the media strategy of Malaysian companies as they reach the global stage, and hopes they realise DNA too is a global media outfit.
Is intellectual property still relevant in the digital age?
Join the discussion this Friday, March 7, at 9.30am at the Sime Darby Convention Centre in KL when DNA founder Karamjit Singh will moderate a panel discussion on whether intellectual property is still relevant in the digital age.
Malaysia’s iGene launches digital autopsy centre in UK
Malaysian advanced medical informatics company iGene Sdn Bhd has launched the first of 18 state-of-the-art digital autopsy facilities for the United Kingdom.
Week in Review: We’re all going to be watching Matt Chandran
This week’s highlight could not be anything other than AIM’s US$22.7 million investment into iGene Sdn Bhd, perhaps the largest venture capital investment ever made into a Malaysian company.
Frustration the trigger for success at iGene
iGene CEO Matt Chandran was doing well providing consultancy and selling a bioinformatics software solution to clients when it hit him that clients 'did not have the will to tap the power of our software to its maximum potential.' That led to his company building on it to deliver its own service.
